Smelson D - Search Results

1

Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.

Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Valenstein M, et al. Among authors: smelson d. Schizophr Bull. 2011 Jul;37(4):727-36. doi: 10.1093/schbul/sbp121. Epub 2009 Nov 21. Schizophr Bull. 2011. PMID: 19933540 Free PMC article. Clinical Trial.

2

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V; Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine. Rosenheck R, et al. Among authors: smelson d. JAMA. 2003 Nov 26;290(20):2693-702. doi: 10.1001/jama.290.20.2693. JAMA. 2003. PMID: 14645311 Clinical Trial.

3

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence.

Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Smelson DA, et al. Can J Psychiatry. 2002 Sep;47(7):671-5. doi: 10.1177/070674370204700710. Can J Psychiatry. 2002. PMID: 12355680 Clinical Trial.

4

Cognitive disparity in schizophrenics with and without cocaine dependency.

Smelson DA, Davis CW, Eisenstein N, Engelhart C, Williams J, Losonczy MF, Ziedonis D. Smelson DA, et al. J Subst Abuse Treat. 2003 Jan;24(1):75-9. doi: 10.1016/s0740-5472(02)00324-0. J Subst Abuse Treat. 2003. PMID: 12646333

5

Serious mental illness and tobacco addiction: a model program to address this common but neglected issue.

Ziedonis D, Williams JM, Smelson D. Ziedonis D, et al. Among authors: smelson d. Am J Med Sci. 2003 Oct;326(4):223-30. doi: 10.1097/00000441-200310000-00014. Am J Med Sci. 2003. PMID: 14557739 Review.

6

Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Smelson DA, et al. CNS Drugs. 2008;22(11):903-16. doi: 10.2165/00023210-200822110-00002. CNS Drugs. 2008. PMID: 18840032 Review.

7

An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine.

Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. Smelson DA, et al. Psychiatr Serv. 2002 Dec;53(12):1612-6. doi: 10.1176/appi.ps.53.12.1612. Psychiatr Serv. 2002. PMID: 12461224

8

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. Smelson DA, et al. J Clin Psychopharmacol. 2006 Feb;26(1):9-12. doi: 10.1097/01.jcp.0000194624.07611.5e. J Clin Psychopharmacol. 2006. PMID: 16415698 Clinical Trial.

9

Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes.

Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Banerjea R, et al. Among authors: smelson d. Am J Drug Alcohol Abuse. 2007;33(6):807-21. doi: 10.1080/00952990701653701. Am J Drug Alcohol Abuse. 2007. PMID: 17994477

10

Mental illness and substance use disorders among women veterans with diabetes.

Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Banerjea R, et al. Among authors: smelson d. Womens Health Issues. 2009 Nov-Dec;19(6):446-56. doi: 10.1016/j.whi.2009.07.007. Womens Health Issues. 2009. PMID: 19879456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page